Vertex Pharmaceuticals
LeaveRussia detail: Continue Operations
Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Business in Russia
Since 2021, pharmaceutical company Vertex has been launching new production sites, and has also opened new quality service analytical laboratories. The company estimates total investments in the development of the Russian's pharmaceutical complex in 2021 and 2022 at about one billion rubles. More than half of this amount was paid for equipment, mainly production equipment, which cost about 385 million rubles. This was reported in the company’s press service.
Decision trail
Decision date 03/02/2022 · Reference ↗
Had a plant in Russia right before invasion, sell their medicines and never made statements about invasion or the cessation of its activities.
Local stats (LeaveRussia)
Status history since 2022
- 03/08/2026 — operating · Imported from KSE LeaveRussia
Exposure profile
Full exposure profile is a Professional feature
Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.
Upgrade to Professional